About
Tellus Therapeutics develops regenerative medicine therapies to treat neonatal white matter brain injury in premature infants, focusing on neuroinflammatory and myelination disorders starting in the NICU.
Explore Tellus Therapeutics's full profile on Brouky
Funding rounds, investor list, and risk signals — unlock with a subscription.